Which melanoma patient carries a BRAF-mutation? A comparison of predictive models

BACKGROUND: In patients with advanced melanoma the detection of BRAF mutations is considered mandatory before the initiation of an expensive treatment with BRAF/MEK inhibitors. Sometimes it is difficult to perform such an analysis if archival tumor tissue is not available and fresh tissue has to be...

Descripción completa

Detalles Bibliográficos
Autores principales: Eigentler, Thomas, Assi, Zeinab, Hassel, Jessica C., Heinzerling, Lucie, Starz, Hans, Berneburg, Mark, Bauer, Jürgen, Garbe, Claus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5094988/
https://www.ncbi.nlm.nih.gov/pubmed/27150060
http://dx.doi.org/10.18632/oncotarget.9143

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5094988/
https://www.ncbi.nlm.nih.gov/pubmed/27150060
http://dx.doi.org/10.18632/oncotarget.9143

Ejemplares similares